New Test Makes Organ Transplants Less Risky - KCBD NewsChannel 11 Lubbock


New Test Makes Organ Transplants Less Risky


Assessing a heart transplant patient's risk for organ rejection just got easier.  The FDA approved a new test called AlloMap, which measures genetic information in a patient's white blood cells.  The test then assigns a score indicating whether the body appears to be rejecting the new organ.  White blood cells are involved in the immune system and help the body fight infection.  The test costs about $3,000.

The previous method to assess rejection required a biopsy of heart tissue.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.